Mingxi Wang

746 total citations
34 papers, 537 citations indexed

About

Mingxi Wang is a scholar working on Molecular Biology, Cancer Research and Endocrinology. According to data from OpenAlex, Mingxi Wang has authored 34 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Endocrinology. Recurrent topics in Mingxi Wang's work include Infections and bacterial resistance (6 papers), MicroRNA in disease regulation (5 papers) and Bacterial biofilms and quorum sensing (4 papers). Mingxi Wang is often cited by papers focused on Infections and bacterial resistance (6 papers), MicroRNA in disease regulation (5 papers) and Bacterial biofilms and quorum sensing (4 papers). Mingxi Wang collaborates with scholars based in China, United States and France. Mingxi Wang's co-authors include Ruian Xu, Xueren Gao, Desong Ming, Shaohua Hu, Tao Jiang, Yajun Zhou, Yaqing Wu, Jianqiong Zhang, Kwok‐Ming Yao and Pik‐to Cheung and has published in prestigious journals such as Journal of Clinical Oncology, Biomaterials and Scientific Reports.

In The Last Decade

Mingxi Wang

30 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingxi Wang China 16 250 96 91 88 59 34 537
Gholamreza Khamisipour Iran 10 181 0.7× 66 0.7× 71 0.8× 17 0.2× 61 1.0× 33 434
Sisi He China 12 350 1.4× 90 0.9× 34 0.4× 31 0.4× 160 2.7× 19 675
Garam Choi South Korea 17 287 1.1× 43 0.4× 73 0.8× 74 0.8× 211 3.6× 35 794
Stuart Hunt United Kingdom 15 423 1.7× 227 2.4× 36 0.4× 115 1.3× 115 1.9× 24 827
Briana Wilson United States 10 499 2.0× 196 2.0× 27 0.3× 60 0.7× 45 0.8× 13 817
Wen Wen China 13 244 1.0× 88 0.9× 20 0.2× 74 0.8× 73 1.2× 26 469
Byunghak Kang South Korea 19 284 1.1× 90 0.9× 38 0.4× 51 0.6× 87 1.5× 37 838
Michelle Kriner United States 8 299 1.2× 81 0.8× 27 0.3× 115 1.3× 104 1.8× 11 536
Siyi Zhang China 19 515 2.1× 258 2.7× 75 0.8× 153 1.7× 122 2.1× 57 1000
Janina P. Lewis United States 17 457 1.8× 87 0.9× 49 0.5× 63 0.7× 34 0.6× 38 1.1k

Countries citing papers authored by Mingxi Wang

Since Specialization
Citations

This map shows the geographic impact of Mingxi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingxi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingxi Wang more than expected).

Fields of papers citing papers by Mingxi Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingxi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingxi Wang. The network helps show where Mingxi Wang may publish in the future.

Co-authorship network of co-authors of Mingxi Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Mingxi Wang. A scholar is included among the top collaborators of Mingxi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingxi Wang. Mingxi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wang, Mingxi, Dandan Wei, Zhen Cui, et al.. (2025). Evaluation of the efficacy and safety of neoadjuvant immunotherapy in locally advanced esophageal squamous cell carcinoma. Journal of Thoracic Disease. 17(3). 1711–1722.
4.
Yang, Yan, Junjun Wang, Hanqi Yang, et al.. (2023). Development and validation of novel immune-inflammation-based clinical predictive nomograms in HER2-negative advanced gastric cancer. Frontiers in Oncology. 13. 1185240–1185240.
5.
Wang, Mingxi, Hongzhi Gao, Ya‐Ping Zhang, et al.. (2019). The antibiotic resistance and pathogenicity of a multidrug‐resistant Elizabethkingia anophelis isolate. MicrobiologyOpen. 8(11). e804–e804. 25 indexed citations
6.
Hu, Shaohua, Yajun Zhou, Tao Jiang, et al.. (2018). Comparative genomic analysis of Myroides odoratimimus isolates. MicrobiologyOpen. 8(2). e00634–e00634. 15 indexed citations
7.
Wang, Mingxi, Xia Zhang, Tao Jiang, et al.. (2017). Liver Abscess Caused by Pannonibacter phragmitetus: Case Report and Literature Review. Frontiers in Medicine. 4. 48–48. 9 indexed citations
8.
Hu, Shaohua, Tao Jiang, Yajun Zhou, et al.. (2017). Elizabethkingia anophelis Isolated from Patients with Multiple Organ Dysfunction Syndrome and Lower Respiratory Tract Infection: Report of Two Cases and Literature Review. Frontiers in Microbiology. 8. 382–382. 19 indexed citations
9.
Hu, Shaohua, Tao Jiang, Yajun Zhou, et al.. (2016). Genomic analysis of the multi-drug-resistant clinical isolate Myroides odoratimimus PR63039. Molecular Genetics and Genomics. 292(1). 133–144. 16 indexed citations
10.
Gao, Xueren, et al.. (2016). TCF21genetic polymorphisms and breast cancer risk in Chinese women. Oncotarget. 7(34). 55757–55764. 16 indexed citations
11.
Hu, Shaohua, Hai Qu, Tao Jiang, et al.. (2016). Antibiotic resistance mechanisms of Myroides sp.. Journal of Zhejiang University SCIENCE B. 17(3). 188–199. 45 indexed citations
12.
Wang, Jie, Xueren Gao, Mingxi Wang, & Jianqiong Zhang. (2015). Clinicopathological significance and biological role of TCF21 mRNA in breast cancer. Tumor Biology. 36(11). 8679–8683. 20 indexed citations
13.
Wang, Mingxi, et al.. (2015). Calcium-ion-modulated ceramic hydroxyapatite resin for the scalable purification of recombinant Adeno-Associated Virus serotype 9. Journal of Chromatography B. 990. 15–22. 6 indexed citations
14.
Gao, Xueren, Jie Wang, Wenjun Wang, Mingxi Wang, & Jianqiong Zhang. (2015). eNOS Genetic Polymorphisms and Cancer Risk. Medicine. 94(26). e972–e972. 27 indexed citations
15.
Gao, Xueren, Huiping Wang, Shulong Zhang, Mingxi Wang, & Zhansheng Zhu. (2015). Pri-miR-124 rs531564 polymorphism and colorectal cancer risk. Scientific Reports. 5(1). 14818–14818. 26 indexed citations
16.
Wang, Mingxi, et al.. (2015). Scalable Downstream Strategies for Purification of Recombinant Adeno- Associated Virus Vectors in Light of the Properties. Current Pharmaceutical Biotechnology. 16(8). 684–695. 56 indexed citations
17.
Bai, Ruyu, Mingxi Wang, Shuyu Lin, et al.. (2015). Kallistatin, a new and reliable biomarker for the diagnosis of liver cirrhosis. Acta Pharmaceutica Sinica B. 5(3). 194–200. 34 indexed citations
18.
Zhang, Shulong, Yong Wang, Mingxi Wang, & Zhenling Ji. (2014). IL-27 −964A>G polymorphism and the risk of breast cancer: a case–control study. Tumor Biology. 35(12). 12099–12102. 11 indexed citations
19.
Li, Jinlei, Junpeng Shi, Jiang‐Shan Shen, et al.. (2014). Specific Recognition of Breast Cancer Cells In Vitro Using Near Infrared-Emitting Long-Persistence Luminescent Zn3Ga2Ge2O10:Cr3+ Nanoprobes. Nano-Micro Letters. 7(2). 138–145. 36 indexed citations
20.
Wong, H. Edward, Mingxi Wang, Pik‐to Cheung, Kwok‐Ming Yao, & Barbara Pui Chan. (2007). A 3D collagen microsphere culture system for GDNF-secreting HEK293 cells with enhanced protein productivity. Biomaterials. 28(35). 5369–5380. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026